Pages that link to "Q36559712"

The following pages link to Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission (Q36559712):

Displaying 41 items.

• The Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and Progression (Q26799181) (← links)
• Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. (Q27308683) (← links)
• Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells (Q28547244) (← links)
• Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages (Q28830321) (← links)
• Signal integration by lipid-mediated spatial cross talk between Ras nanoclusters (Q33623159) (← links)
• A high-throughput assay for small molecule destabilizers of the KRAS oncoprotein (Q34004748) (← links)
• Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators (Q34659415) (← links)
• Oligomycins as inhibitors of K-Ras plasma membrane localisation. (Q35840615) (← links)
• Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells (Q35987390) (← links)
• RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies (Q36398735) (← links)
• Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane. (Q36480870) (← links)
• Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function (Q36950248) (← links)
• KRAS - An Evolving Cancer Target (Q37261936) (← links)
• Lessons from computer simulations of Ras proteins in solution and in membrane (Q37301995) (← links)
• Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy. (Q37444285) (← links)
• AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2. (Q37448013) (← links)
• Caveolae regulate the nanoscale organization of the plasma membrane to remotely control Ras signaling (Q37614846) (← links)
• Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling (Q38262838) (← links)
• Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery? (Q38423044) (← links)
• Computational allosteric ligand binding site identification on Ras proteins. (Q38612789) (← links)
• Drugging RAS: Know the enemy (Q39182842) (← links)
• Comparative proteomic analysis of compartmentalised Ras signalling (Q40259833) (← links)
• Deciphering lipid codes: K-Ras as a paradigm (Q46264996) (← links)
• Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies (Q47239374) (← links)
• A novel prenyl-polybasic domain code determines lipid-binding specificity of the K-Ras membrane anchor (Q47294739) (← links)
• DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, is a putative tumor suppressor (Q47412009) (← links)
• Plasma membrane phosphatidylinositol 4-phosphate and 4,5-bisphosphate determine the distribution and function of K-Ras4B but not H-Ras proteins. (Q47758406) (← links)
• Lipid-Sorting Specificity Encoded in K-Ras Membrane Anchor Regulates Signal Output (Q49243022) (← links)
• Ras and the Plasma Membrane: A Complicated Relationship (Q49921459) (← links)
• Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer (Q51119632) (← links)
• Positive feedback can lead to dynamic nanometer-scale clustering on cell membranes. (Q53249474) (← links)
• Sphingomyelin metabolism is a regulator of KRAS function. (Q54137051) (← links)
• Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding (Q64233821) (← links)
• An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth (Q89410953) (← links)
• Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2pos Disease (Q89634316) (← links)
• Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway (Q90220998) (← links)
• From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers (Q90357653) (← links)
• K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function (Q91814627) (← links)
• Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC (Q92118036) (← links)
• Galectin-8 binds to the Farnesylated C-terminus of K-Ras4B and Modifies Ras/ERK Signaling and Migration in Pancreatic and Lung Carcinoma Cells (Q92156695) (← links)
• Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors (Q92946134) (← links)